BIOMAT Database Logo BIOMAT Database Logo

Inhibition of zaleplon metabolism by cimetidine in the human liver: in vitro studies with subcellular fractions and precision-cut liver slices. 2002

A B Renwick, and S E Ball, and J M Tredger, and R J Price, and D G Walters, and J Kao, and J A Scatina, and B G Lake
TNO BIBRA International Ltd, Woodmansterne Road, Carshalton, Surrey SM5 4DS, UK.

1. The effect of cimetidine on the metabolism of zaleplon (ZAL) in human liver subcellular fractions and precision-cut liver slices was investigated. 2. ZAL was metabolized to a number of products including 5-oxo-ZAL (M2), which is known to be formed by aldehyde oxidase, N-desethyl-ZAL (DZAL), which is known to be formed by CYP3A forms, and N-desethyl-5-oxo-ZAL (M1). 3. Human liver microsomes catalysed the NADPH-dependent metabolism of ZAL to DZAL. Kinetic analysis of three microsomal preparations revealed mean (+/-SEM) S(50) and V(max) of 310 +/- 24 micro M and 920 +/- 274 pmol/min/mg protein, respectively. 4. Human liver cytosol preparations catalysed the metabolism of ZAL to M2. Kinetic analysis of three cytosol preparations revealed mean (+/-SEM), K(m) and V(max) of 124 +/- 14 micro M and 564 +/- 143 pmol/min/mg protein, respectively. 5. Cimetidine inhibited ZAL metabolism to DZAL in liver microsomes and to M2 in the liver cytosol. With a ZAL substrate concentration of 62 micro M, the calculated mean (+/-SEM, n = 3) IC50 were 596 +/- 103 and 231 +/- 23 micro M for DZAL and M2 formation, respectively. Kinetic analysis revealed that cimetidine was a competitive inhibitor of M2 formation in liver cytosol with a mean (+/-SEM, n = 3) K(i) of 155 +/- 16 micro M. 6. Freshly cut human liver slices metabolized ZAL to a number of products including 1, M2 and DZAL. 7. Cimetidine inhibited ZAL metabolism in liver slices to M1 and M2, but not to DZAL. Kinetic analysis revealed that cimetidine was a competitive inhibitor of M2 formation in liver slices with an average (n = 2 preparations) K(i) of 506 micro M. 8. The results demonstrate that cimetidine can inhibit both the CYP3A and aldehyde oxidase pathways of ZAL metabolism in the human liver. Cimetidine appears to be a more potent inhibitor of aldehyde oxidase than of CYP3A forms and hence in vivo is likely to have a more marked effect on ZAL metabolism to M2 than on DZAL formation. 9. The results also demonstrate that precision-cut liver slices may be a useful model system for in vitro drug-interaction studies.

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme

Related Publications

A B Renwick, and S E Ball, and J M Tredger, and R J Price, and D G Walters, and J Kao, and J A Scatina, and B G Lake
In vitro metabolism of lidocaine in subcellular post-mitochondrial fractions and precision cut slices from cattle liver.
October 2021, Toxicology in vitro : an international journal published in association with BIBRA,
A B Renwick, and S E Ball, and J M Tredger, and R J Price, and D G Walters, and J Kao, and J A Scatina, and B G Lake
Testosterone metabolism in slices and subcellular fractions of human liver.
January 1973, Acta endocrinologica. Supplementum,
A B Renwick, and S E Ball, and J M Tredger, and R J Price, and D G Walters, and J Kao, and J A Scatina, and B G Lake
In Vitro metabolism of ciclesonide in human lung and liver precision-cut tissue slices.
May 2006, Biopharmaceutics & drug disposition,
A B Renwick, and S E Ball, and J M Tredger, and R J Price, and D G Walters, and J Kao, and J A Scatina, and B G Lake
Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.
September 1996, Drug metabolism and disposition: the biological fate of chemicals,
A B Renwick, and S E Ball, and J M Tredger, and R J Price, and D G Walters, and J Kao, and J A Scatina, and B G Lake
On-line HPLC analysis system for metabolism and inhibition studies in precision-cut liver slices.
January 2011, Analytical chemistry,
A B Renwick, and S E Ball, and J M Tredger, and R J Price, and D G Walters, and J Kao, and J A Scatina, and B G Lake
In-vitro metabolic studies of tacrolimus using precision-cut rat and human liver slices.
December 1996, Journal of pharmaceutical and biomedical analysis,
A B Renwick, and S E Ball, and J M Tredger, and R J Price, and D G Walters, and J Kao, and J A Scatina, and B G Lake
PI3K inhibition reduces murine and human liver fibrogenesis in precision-cut liver slices.
November 2019, Biochemical pharmacology,
A B Renwick, and S E Ball, and J M Tredger, and R J Price, and D G Walters, and J Kao, and J A Scatina, and B G Lake
Metabolism of coumarin by precision-cut calf liver slices and calf liver microsomes.
February 1995, Xenobiotica; the fate of foreign compounds in biological systems,
A B Renwick, and S E Ball, and J M Tredger, and R J Price, and D G Walters, and J Kao, and J A Scatina, and B G Lake
Development of a simple incubation system for metabolism studies with precision-cut liver slices.
January 1993, Drug metabolism and disposition: the biological fate of chemicals,
A B Renwick, and S E Ball, and J M Tredger, and R J Price, and D G Walters, and J Kao, and J A Scatina, and B G Lake
Precision-cut intestinal slices as in vitro tool for studies on drug metabolism.
January 2013, Current drug metabolism,
Copied contents to your clipboard!